International Journal of Endocrinology / 2016 / Article / Tab 1

Clinical Study

Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial

Table 1

Patient characteristics.

TAXVPA + TAX

Number of enrolled patients1411

Gender
 (i) Male85
 (ii) Female66

Age (years)
 (i) Median73.566
 (ii) Range62–8344–80

Disease stage
 (i) 4A11
 (ii) 4B15
 (iii) 4C125

Distant metastasis
 (i) Lymph nodes54
 (ii) Lung 72

Previous therapy
 (i) Radiotherapy67
 (ii) Chemotherapy47
 (iii) Thyroidectomy (incomplete)7 R0/R1 (1 R2)8 R0/R1 (1 R2)

R0/R1: macroscopically complete resection; R2 resection with minimal macroscopical residual tumor.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.